ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR EpitopeAndrew C. Phillips, Edward B. Reilly, Laura M. McKay et al.|Molecular Cancer Therapeutics|2016Cited by 185
Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid TumorsDarren C. Phillips, Susan E. Morgan-Lappe, Fritz G. Buchanan et al.|Cancer Research|2021Cited by 52
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)Michael L. Curtin, Michael R. Michaelides, H. Robin Heyman et al.|Bioorganic & Medicinal Chemistry Letters|2017Cited by 21
Utilization of 18F-Fluorodeoxyglucose–Positron Emission Tomography To Understand the Mechanism of Nicotinamide Phosphoribosyltransferase Inhibitors In VivoSarah R. Mudd, Julie L. Wilsbacher, Martin J. Voorbach et al.|Journal of Pharmacology and Experimental Therapeutics|2019Cited by 3
Abstract 3059: Discovery of BET family proteins as cancer targets using phenotypic-based profiling and affinity capture mass spectrometryScott E. Warder, Yu Shen, Shaun M. McLoughlin et al.|Cancer Research|2016Cited by 0